The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Type 2 Diabetes Market Research Report 2024
Synopsis
Type 2 diabetes is a progressive condition in which the body becomes resistant to the normal effects of insulin and/or gradually loses the capacity to produce enough insulin in the pancreas. We do not know what causes type 2 diabetes. Type 2 diabetes is associated with modifiable lifestyle risk factors. Type 2 diabetes also has strong genetic and family related risk factors.
The global Type 2 Diabetes market was valued at US$ 65110 million in 2023 and is anticipated to reach US$ 118340 million by 2030, witnessing a CAGR of 8.8% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Type 2 Diabetes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Type 2 Diabetes.
Report Scope
The Type 2 Diabetes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Type 2 Diabetes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Type 2 Diabetes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Sanofi
Merck
Eli Lily
AstraZeneca
Astellas Pharma
Daiichi Sankyo
Biocon
Boehringer Ingelheim
Segment by Type
Insulins
DPP-4 Inhibitors
GLP-1 Receptor Agonists
SGLT-2 Inhibitors
Segment by Application
Drugstore
Hospital
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Type 2 Diabetes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Type 2 Diabetes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Type 2 diabetes is a progressive condition in which the body becomes resistant to the normal effects of insulin and/or gradually loses the capacity to produce enough insulin in the pancreas. We do not know what causes type 2 diabetes. Type 2 diabetes is associated with modifiable lifestyle risk factors. Type 2 diabetes also has strong genetic and family related risk factors.
The global Type 2 Diabetes market was valued at US$ 65110 million in 2023 and is anticipated to reach US$ 118340 million by 2030, witnessing a CAGR of 8.8% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Type 2 Diabetes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Type 2 Diabetes.
Report Scope
The Type 2 Diabetes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Type 2 Diabetes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Type 2 Diabetes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Sanofi
Merck
Eli Lily
AstraZeneca
Astellas Pharma
Daiichi Sankyo
Biocon
Boehringer Ingelheim
Segment by Type
Insulins
DPP-4 Inhibitors
GLP-1 Receptor Agonists
SGLT-2 Inhibitors
Segment by Application
Drugstore
Hospital
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Type 2 Diabetes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Type 2 Diabetes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Type 2 Diabetes Market Overview
1.1 Product Overview and Scope of Type 2 Diabetes
1.2 Type 2 Diabetes Segment by Type
1.2.1 Global Type 2 Diabetes Market Value Comparison by Type (2024-2030)
1.2.2 Insulins
1.2.3 DPP-4 Inhibitors
1.2.4 GLP-1 Receptor Agonists
1.2.5 SGLT-2 Inhibitors
1.3 Type 2 Diabetes Segment by Application
1.3.1 Global Type 2 Diabetes Market Value by Application: (2024-2030)
1.3.2 Drugstore
1.3.3 Hospital
1.3.4 Others
1.4 Global Type 2 Diabetes Market Size Estimates and Forecasts
1.4.1 Global Type 2 Diabetes Revenue 2019-2030
1.4.2 Global Type 2 Diabetes Sales 2019-2030
1.4.3 Global Type 2 Diabetes Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Type 2 Diabetes Market Competition by Manufacturers
2.1 Global Type 2 Diabetes Sales Market Share by Manufacturers (2019-2024)
2.2 Global Type 2 Diabetes Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Type 2 Diabetes Average Price by Manufacturers (2019-2024)
2.4 Global Type 2 Diabetes Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Type 2 Diabetes, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Type 2 Diabetes, Product Type & Application
2.7 Type 2 Diabetes Market Competitive Situation and Trends
2.7.1 Type 2 Diabetes Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Type 2 Diabetes Players Market Share by Revenue
2.7.3 Global Type 2 Diabetes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Type 2 Diabetes Retrospective Market Scenario by Region
3.1 Global Type 2 Diabetes Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Type 2 Diabetes Global Type 2 Diabetes Sales by Region: 2019-2030
3.2.1 Global Type 2 Diabetes Sales by Region: 2019-2024
3.2.2 Global Type 2 Diabetes Sales by Region: 2025-2030
3.3 Global Type 2 Diabetes Global Type 2 Diabetes Revenue by Region: 2019-2030
3.3.1 Global Type 2 Diabetes Revenue by Region: 2019-2024
3.3.2 Global Type 2 Diabetes Revenue by Region: 2025-2030
3.4 North America Type 2 Diabetes Market Facts & Figures by Country
3.4.1 North America Type 2 Diabetes Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Type 2 Diabetes Sales by Country (2019-2030)
3.4.3 North America Type 2 Diabetes Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Type 2 Diabetes Market Facts & Figures by Country
3.5.1 Europe Type 2 Diabetes Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Type 2 Diabetes Sales by Country (2019-2030)
3.5.3 Europe Type 2 Diabetes Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Type 2 Diabetes Market Facts & Figures by Country
3.6.1 Asia Pacific Type 2 Diabetes Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Type 2 Diabetes Sales by Country (2019-2030)
3.6.3 Asia Pacific Type 2 Diabetes Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Type 2 Diabetes Market Facts & Figures by Country
3.7.1 Latin America Type 2 Diabetes Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Type 2 Diabetes Sales by Country (2019-2030)
3.7.3 Latin America Type 2 Diabetes Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Type 2 Diabetes Market Facts & Figures by Country
3.8.1 Middle East and Africa Type 2 Diabetes Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Type 2 Diabetes Sales by Country (2019-2030)
3.8.3 Middle East and Africa Type 2 Diabetes Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Type 2 Diabetes Sales by Type (2019-2030)
4.1.1 Global Type 2 Diabetes Sales by Type (2019-2024)
4.1.2 Global Type 2 Diabetes Sales by Type (2025-2030)
4.1.3 Global Type 2 Diabetes Sales Market Share by Type (2019-2030)
4.2 Global Type 2 Diabetes Revenue by Type (2019-2030)
4.2.1 Global Type 2 Diabetes Revenue by Type (2019-2024)
4.2.2 Global Type 2 Diabetes Revenue by Type (2025-2030)
4.2.3 Global Type 2 Diabetes Revenue Market Share by Type (2019-2030)
4.3 Global Type 2 Diabetes Price by Type (2019-2030)
5 Segment by Application
5.1 Global Type 2 Diabetes Sales by Application (2019-2030)
5.1.1 Global Type 2 Diabetes Sales by Application (2019-2024)
5.1.2 Global Type 2 Diabetes Sales by Application (2025-2030)
5.1.3 Global Type 2 Diabetes Sales Market Share by Application (2019-2030)
5.2 Global Type 2 Diabetes Revenue by Application (2019-2030)
5.2.1 Global Type 2 Diabetes Revenue by Application (2019-2024)
5.2.2 Global Type 2 Diabetes Revenue by Application (2025-2030)
5.2.3 Global Type 2 Diabetes Revenue Market Share by Application (2019-2030)
5.3 Global Type 2 Diabetes Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Type 2 Diabetes Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novo Nordisk Type 2 Diabetes Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Type 2 Diabetes Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Type 2 Diabetes Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Type 2 Diabetes Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Type 2 Diabetes Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Eli Lily
6.4.1 Eli Lily Corporation Information
6.4.2 Eli Lily Description and Business Overview
6.4.3 Eli Lily Type 2 Diabetes Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eli Lily Type 2 Diabetes Product Portfolio
6.4.5 Eli Lily Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Type 2 Diabetes Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AstraZeneca Type 2 Diabetes Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Astellas Pharma
6.6.1 Astellas Pharma Corporation Information
6.6.2 Astellas Pharma Description and Business Overview
6.6.3 Astellas Pharma Type 2 Diabetes Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Astellas Pharma Type 2 Diabetes Product Portfolio
6.6.5 Astellas Pharma Recent Developments/Updates
6.7 Daiichi Sankyo
6.6.1 Daiichi Sankyo Corporation Information
6.6.2 Daiichi Sankyo Description and Business Overview
6.6.3 Daiichi Sankyo Type 2 Diabetes Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Daiichi Sankyo Type 2 Diabetes Product Portfolio
6.7.5 Daiichi Sankyo Recent Developments/Updates
6.8 Biocon
6.8.1 Biocon Corporation Information
6.8.2 Biocon Description and Business Overview
6.8.3 Biocon Type 2 Diabetes Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biocon Type 2 Diabetes Product Portfolio
6.8.5 Biocon Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Corporation Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim Type 2 Diabetes Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Boehringer Ingelheim Type 2 Diabetes Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Type 2 Diabetes Industry Chain Analysis
7.2 Type 2 Diabetes Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Type 2 Diabetes Production Mode & Process
7.4 Type 2 Diabetes Sales and Marketing
7.4.1 Type 2 Diabetes Sales Channels
7.4.2 Type 2 Diabetes Distributors
7.5 Type 2 Diabetes Customers
8 Type 2 Diabetes Market Dynamics
8.1 Type 2 Diabetes Industry Trends
8.2 Type 2 Diabetes Market Drivers
8.3 Type 2 Diabetes Market Challenges
8.4 Type 2 Diabetes Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
